Management of complicated proliferative diabetic retinopathy in a patient with oculocutaneous albinism.

Diabetes Hypopigmented fundus Oculocutaneous albinism Proliferative diabetic retinopathy

Journal

American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 22 01 2022
revised: 01 08 2022
accepted: 02 08 2022
entrez: 29 8 2022
pubmed: 30 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

To describe the management and outcome of a patient with oculocutaneous albinism and complicated proliferative diabetic retinopathy, as well as to discuss treatment challenges and strategies in this patient population. A 52-year-old patient with oculocutaneous albinism and diabetes presented with light perception vision in her right eye and 20/300 vision in her left eye. Examination showed a diabetic tractional retinal detachment in the right eye and high-risk proliferative diabetic retinopathy (PDR) in the left eye. In the right eye, the patient underwent pars plana vitrectomy, membrane delamination, endolaser therapy, and silicone oil tamponade, with follow-up evaluations showing a flat retina under silicone oil with regressed retinopathy in this eye. In her left eye, pan-retinal photocoagulation was attempted without success, with persistent PDR and absence of laser marks in this eye. Subsequently, the patient underwent six intravitreal anti-VEGF injections, after which she developed a tractional retinal detachment necessitating treatment cessation and a planned surgical intervention. This case highlights the difficulty of using standard medical and surgical treatment strategies when caring for patients with oculocutaneous albinism and complicated proliferative diabetic retinopathy. If medical treatments fail in these patients, surgical approaches should be planned with extreme care due to the risks and challenges posed by hypopigmented fundi. Interventional case report.

Identifiants

pubmed: 36034765
doi: 10.1016/j.ajoc.2022.101681
pii: S2451-9936(22)00427-3
pmc: PMC9399137
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101681

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The following authors have no financial disclosures, Marshoud A., Judaibi R., Alkhaldi H, Mura M.

Références

Clin Ophthalmol. 2018 Apr 05;12:651-656
pubmed: 29670325
JAMA. 2015 Nov 24;314(20):2137-2146
pubmed: 26565927
Eye (Lond). 2016 Mar;30(3):422-5
pubmed: 26611845
Br J Ophthalmol. 2012 Apr;96(4):587-90
pubmed: 22289291
Lancet. 2017 Jun 3;389(10085):2193-2203
pubmed: 28494920
Br J Ophthalmol. 2008 Feb;92(2):213-6
pubmed: 17965108

Auteurs

Abdullah Al Marshood (AA)

Ophthalmology Department, Qassim University, Qassim, Saudi Arabia.

Ramzi Al Judaibi (R)

Consultant Ophthalmologist, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.

Hamdah Alkhaldi (H)

Ophthalmology Resident, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Marco Mura (M)

King Khaled Eye Specialist Hospital and Department of Ophthalmology, University of Illinois, Chicago, USA.

Classifications MeSH